Rose, T. L., Weir, W. H., Mayhew, G. M., Shibata, Y., Eulitt, P., Uronis, J. M., … Kim, W. Y. (2022). Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience. Br J Cancer, 126(8), 1237. https://doi.org/10.1038/s41416-022-01781-y

Rose, Tracy L., William H. Weir, Gregory M. Mayhew, Yoichiro Shibata, Patrick Eulitt, Joshua M. Uronis, Mi Zhou, et al. “Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience.” Br J Cancer 126, no. 8 (May 2022): 1237. https://doi.org/10.1038/s41416-022-01781-y.

Rose TL, Weir WH, Mayhew GM, Shibata Y, Eulitt P, Uronis JM, et al. Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience. Br J Cancer. 2022 May;126(8):1237.

Rose, Tracy L., et al. “Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience.” Br J Cancer, vol. 126, no. 8, May 2022, p. 1237. Pubmed, doi:10.1038/s41416-022-01781-y.

Rose TL, Weir WH, Mayhew GM, Shibata Y, Eulitt P, Uronis JM, Zhou M, Nielsen M, Smith AB, Woods M, Hayward MC, Salazar AH, Milowsky MI, Wobker SE, McGinty K, Millburn MV, Eisner JR, Kim WY. Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience. Br J Cancer. 2022 May;126(8):1237.